Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.260
-0.040 (-1.74%)
At close: May 7, 2026, 4:00 PM EDT
2.330
+0.070 (3.10%)
Pre-market: May 8, 2026, 4:08 AM EDT
Pyxis Oncology Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$6.83
Upside
+202.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Initiates $6 | Buy | Initiates | $6 | +165.49% | May 5, 2026 |
| Stifel | Stifel | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +253.98% | Mar 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +209.73% | Mar 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +121.24% | Dec 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +209.73% | Dec 19, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +253.98% | Nov 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +209.73% | Nov 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +121.24% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +121.24% | Aug 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +121.24% | May 19, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +253.98% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +121.24% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 → $5 | Strong Buy | Reiterates | $7 → $5 | +121.24% | Dec 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 → $8 | Buy | Reiterates | $10 → $8 | +253.98% | Dec 20, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $10 | Buy | Maintains | $7 → $10 | +342.48% | Nov 21, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.